XFOR’s short interest reaches 11.99 million shares on Jan 11, 2024

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. X4 Pharmaceuticals Inc shares valued at $35,915 were sold by Ragan Paula on Nov 03. At $0.90 per share, Ragan Paula sold 39,906 shares. The insider’s holdings dropped to 836,441 shares worth approximately $0.65 million following the completion of this transaction.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.
Sponsored

Also, Mostafa Adam S. sold 230,645 shares, netting a total of over 168,371 in proceeds. Following the sale of shares at $0.73 each, the insider now holds 80,221 shares.

Before that, Ragan Paula had sold 199,531 shares from its account. In a trade valued at $145,658, the President and CEO traded X4 Pharmaceuticals Inc shares for $0.73 each. Upon closing the transaction, the insider’s holdings decreased to 199,531 shares, worth approximately $0.68 million.

As published in a research note from B. Riley Securities on December 12, 2023, X4 Pharmaceuticals Inc [XFOR] has been rated down from a Buy to a Neutral and the price target has been revised to $1 from $3.

Analyzing XFOR Stock Performance

During the last five days, there has been a surge of approximately 8.53%. Over the course of the year, X4 Pharmaceuticals Inc shares have dropped approximately -6.81%. Shares of the company reached a 52-week high of $0.9155 on 01/02/24 and a 52-week low of $0.7004 on 01/25/24. A 50-day SMA is recorded $0.7848, while a 200-day SMA reached $1.2846. Nevertheless, trading volume fell to 0.74 million shares from 2.04 million shares the previous day.

Support And Resistance Levels for X4 Pharmaceuticals Inc (XFOR)

According to the 24-hour chart, there is a support level at 0.7578, which, if violated, would cause prices to drop to 0.7341. In the upper region, resistance lies at 0.8175. The next price resistance is at 0.8535. RSI (Relative Strength Index) is 49.14 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.0295, which suggests the price will decrease in the coming days. Percent R is at 50.64%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.

Is X4 Pharmaceuticals Inc subject to short interest?

Stocks of X4 Pharmaceuticals Inc saw a sharp rise in short interest on Jan 11, 2024 jumping by 0.25 million shares to 11.99 million. Data from Yahoo Finance shows that the short interest on Dec 14, 2023 was 11.74 million shares. A jump of 2.09% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 6.59 of the overall float, the days-to-cover ratio (short ratio) jumped to 6.59.

Leave a Reply

Your email address will not be published. Required fields are marked *

Most Popular